Shao-Lee Lin
Director, Chief Executive Officer; Director, CHIEF EXECUTIVE OFFICER · 5 filings · Latest: Aug 12, 2026
Cue Biopharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CUE | Shao-Lee Lin | Director, Chief Executive Officer | Aug 13, 2026 | Sale | $28.62 | 18,258 | $522.6K | 705,995 | |
CUE | Shao-Lee Lin | Director, Chief Executive Officer | Aug 12, 2026 | Sale | $27.10 | 40,000 | $1.1M | 724,253 | |
CUE | Shao-Lee Lin | Director, Chief Executive Officer | Aug 12, 2026 | Option Exercise | $0.00 | 109,179 | — | 764,253 | |
CUE | Shao-Lee Lin | — | Aug 13, 2026 | Proposed Sale | $27.40 | 58,258 | $1.6M | — |